%0 Journal Article
%T Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer
%A Choonghoon Lee
%A Eunjin Lee
%A Hun Jung
%A Ji-Yeon Kim
%A Jin Seok Ahn
%A Kyunghee Park
%A Razvan Cristescu
%A Song Ee Park
%A Soo Youn Cho
%A Woong-Yang Park
%A Yeon Hee Park
%A Young-Hyuck Im
%J Archive of "Oncoimmunology".
%D 2018
%R 10.1080/2162402X.2018.1466768
%K Tumor mutational burden (TMB)
%K Human epidermal growth factor receptor 2 (HER2)
%K Metastatic breast cancer (MBC)
%K Long survival outcomes
%K whole exome sequencing (WES)
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136852/